These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14658966)

  • 1. Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial.
    Steiner H; Petersen ML; Saxena K; Ford S; Matthews Z
    J Clin Psychiatry; 2003 Oct; 64(10):1183-91. PubMed ID: 14658966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divalproex sodium for the treatment of PTSD and conduct disordered youth: a pilot randomized controlled clinical trial.
    Steiner H; Saxena KS; Carrion V; Khanzode LA; Silverman M; Chang K
    Child Psychiatry Hum Dev; 2007 Oct; 38(3):183-93. PubMed ID: 17570057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline predictors of response to divalproex in conduct disorder.
    Saxena K; Silverman MA; Chang K; Khanzode L; Steiner H
    J Clin Psychiatry; 2005 Dec; 66(12):1541-8. PubMed ID: 16401155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.
    Hollander E; Allen A; Lopez RP; Bienstock CA; Grossman R; Siever LJ; Merkatz L; Stein DJ
    J Clin Psychiatry; 2001 Mar; 62(3):199-203. PubMed ID: 11305707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.
    Frankenburg FR; Zanarini MC
    J Clin Psychiatry; 2002 May; 63(5):442-6. PubMed ID: 12019669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy profiles of psychopharmacology: divalproex sodium in conduct disorder.
    Khanzode LA; Saxena K; Kraemer H; Chang K; Steiner H
    Child Psychiatry Hum Dev; 2006; 37(1):55-64. PubMed ID: 16927177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic response to divalproex in subtypes of conduct disorder.
    Padhy R; Saxena K; Remsing L; Huemer J; Plattner B; Steiner H
    Child Psychiatry Hum Dev; 2011 Oct; 42(5):584-93. PubMed ID: 21706221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder.
    Connor DF; McLaughlin TJ; Jeffers-Terry M
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):140-56. PubMed ID: 18439112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label trial of divalproex extended-release in the treatment of borderline personality disorder.
    Simeon D; Baker B; Chaplin W; Braun A; Hollander E
    CNS Spectr; 2007 Jun; 12(6):439-43. PubMed ID: 17545954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divalproex sodium for impulsive aggressive behavior in patients with personality disorder.
    Kavoussi RJ; Coccaro EF
    J Clin Psychiatry; 1998 Dec; 59(12):676-80. PubMed ID: 9921702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.
    MacMillan CM; Withney JE; Korndörfer SR; Tilley CA; Mrakotsky C; Gonzalez-Heydrich JM
    J Psychiatr Pract; 2008 May; 14(3):160-9. PubMed ID: 18520785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divalproex sodium as a treatment for borderline personality disorder.
    Wilcox JA
    Ann Clin Psychiatry; 1995 Mar; 7(1):33-7. PubMed ID: 8541935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
    Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder.
    Malone RP; Delaney MA; Luebbert JF; Cater J; Campbell M
    Arch Gen Psychiatry; 2000 Jul; 57(7):649-54. PubMed ID: 10891035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease.
    Profenno LA; Jakimovich L; Holt CJ; Porsteinsson A; Tariot PN
    Curr Alzheimer Res; 2005 Dec; 2(5):553-8. PubMed ID: 16375658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinical trial.
    Papatheodorou G; Kutcher SP; Katic M; Szalai JP
    J Clin Psychopharmacol; 1995 Apr; 15(2):110-6. PubMed ID: 7782483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania.
    State RC; Frye MA; Altshuler LL; Strober M; DeAntonio M; Hwang S; Mintz J
    J Clin Psychiatry; 2004 Aug; 65(8):1057-63. PubMed ID: 15323589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.
    Hollander E; Swann AC; Coccaro EF; Jiang P; Smith TB
    Am J Psychiatry; 2005 Mar; 162(3):621-4. PubMed ID: 15741486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
    Barzman DH; DelBello MP; Adler CM; Stanford KE; Strakowski SM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.